Manion Douglas J.
- SEC CIK
- 0001875875
No open-market purchases or sales filed in the past year.
Current role at each company
- ACRS Aclaris Therapeutics, Inc.Pres and CEOas of Jan 3, 2024
- ARNA Arena Pharmaceuticals IncEVP Research & Developmentas of Mar 11, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Manion Douglas J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACRS Aclaris Therapeutics, Inc.
Pres and CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2023 (view filing) | Mar 17 | Same day | Manion Douglas J.Pres and CEO | PPurchase | +6.30K | $7.86 | +$49.5K | +96.9%12.8K after | |
| Mar 9, 2023 (view filing) | Mar 9 | Same day | Manion Douglas J.Pres and CEO | PPurchase | +6.50K | $7.74 | +$50.3K | New position6.50K after |